Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07214480 · ClinicalTrials.gov registry record · NA

Treatment for /s/ Production Errors in Children With Speech Sound Errors

A NA study of Speech Sound Disorder, sponsored by Syracuse University.

Recruiting
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT07214480: Recruiting NA study of Speech Sound Disorder, sponsored by Syracuse University.

NCT07214480 is a NA study of Speech Sound Disorder that is actively recruiting participants, run by Syracuse University. The registered enrollment target is 24 participants, below the 88-participant average among 15 other Speech Sound Disorder trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07214480, a NA study of Speech Sound Disorder, is actively recruiting participants, sponsored by Syracuse University.

RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

We want to learn about a new way to help people make the /s/ sound, like in the word "snake." We will be studying a way to teach the /s/ sound that uses very short speech sessions. This study will also collect recordings from people as they say words with the /s/ sound. We will listen to these recordings and check if the words are said clearly. In the first visit, we'll do a speech lesson on how to make a clear /s/ sound. We will also have the participant say some words while we record them talking. If they are a good fit for the study, we will invite them to do a second visit. In the second visit, they will name some pictures, answer some questions, repeat words and sentences, and do some mouth movements. After the second visit, if they are a good fit for the study, we will invite them to do the speech lessons. The speech lessons will each take 10 minutes, and they will have lessons 4 times a week for 8 weeks. They will do these lessons on video chat. They will be randomized to either start right away or after 8 weeks. We'll also ask them to participate in 3 other visits to track progress by having them repeat words with /s/.

Primary Outcome

Children will imitate syllables and words containing the /s/ sound. Listeners who are masked to treatment condition and timepoint will listen to recordings of these words and rate the accuracy along a 5 point scale, where 1 is incorrect (speech sound omission or substitution) and 5 is fully correct /s/.

Conditions Studied

Interventions

  • BEHAVIORAL Motor-based speech treatment

Study Locations (1)

New York

  • Syracuse University - Syracuse

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2025-06-09
Est. Completion 2027-01
Phase NA
Syracuse University

31 total trials

What NCT07214480 shows while recruiting

NCT07214480 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 88-participant average among 15 other Speech Sound Disorder trials with a reported enrollment target (73% lower).

The record links to 1 condition, with Speech Sound Disorder appearing as the primary indexed condition, and to 1 intervention - of which Motor-based speech treatment is the first listed.

NCT07214480 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT07214480 about?

NCT07214480 is a clinical study titled "Treatment for /s/ Production Errors in Children With Speech Sound Errors". We want to learn about a new way to help people make the /s/ sound, like in the word "snake." We will be studying a way to teach the /s/ sound that uses very short speech sessions. This study will also collect recordings from people as they say words with the /s/ sound. We will listen to these recor...

What is the current status of trial NCT07214480?

This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2025-06-09. Estimated completion is 2027-01.

What conditions does trial NCT07214480 study?

This clinical trial studies the following conditions: Speech Sound Disorder.

What interventions are being tested in trial NCT07214480?

The interventions under investigation include: Motor-based speech treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT07214480?

This trial is sponsored by Syracuse University, which has 31 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07214480 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Speech Sound Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07214480's enrollment target sits among peer trials

24 13th of 15 higher than 2 of 15 other Speech Sound Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Speech Sound Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07214480, the US trial registry maintained by the National Library of Medicine. NCT07214480 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.